HLA class I histocompatibility antigen, alpha chain E
Definition:
References:
-
[1]. V M Braud, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998 Feb 19;391(6669):795-9. [Content Brief]
[2]. Daria Bortolotti, et al. SARS-CoV-2 Spike 1 Protein Controls Natural Killer Cell Activation via the HLA-E/NKG2A Pathway. Cells. 2020 Aug 26;9(9):1975. [Content Brief]
[3]. Hilary L Hoare, et al. Structural basis for a major histocompatibility complex class Ib-restricted T cell response. Nat Immunol. 2006 Mar;7(3):256-64. [Content Brief]
[4]. Jakob Michaëlsson, et al. A signal peptide derived from hsp60 binds HLA-E and interferes with CD94/NKG2A recognition. J Exp Med. 2002 Dec 2;196(11):1403-14. [Content Brief]
[5]. Stéphanie Coupel, et al. Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood. 2007 Apr 1;109(7):2806-14. [Content Brief]
[6]. Alexander Rölle, et al. Distinct HLA-E Peptide Complexes Modify Antibody-Driven Effector Functions of Adaptive NK Cells. Cell Rep. 2018 Aug 21;24(8):1967-1976.e4. [Content Brief]
[7]. Jacob Nattermann, et al. HIV-1 infection leads to increased HLA-E expression resulting in impaired function of natural killer cells. Antivir Ther. 2005;10(1):95-107. [Content Brief]
[8]. Lucy C Sullivan, et al. The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-E recognition. Immunity. 2007 Dec;27(6):900-11. [Content Brief]
[9]. M Ulbrecht, et al. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. J Immunol. 2000 May 15;164(10):5019-22. [Content Brief]
[10]. Lucy C Walters, et al. Pathogen-derived HLA-E bound epitopes reveal broad primary anchor pocket tolerability and conformationally malleable peptide binding. Nat Commun. 2018 Aug 7;9(1):3137. [Content Brief]
[11]. Susan L Heatley, et al. Polymorphism in human cytomegalovirus UL40 impacts on recognition of human leukocyte antigen-E (HLA-E) by natural killer cells. J Biol Chem. 2013 Mar 22;288(12):8679-8690. [Content Brief]
[12]. M Llano, et al. HLA-E-bound peptides influence recognition by inhibitory and triggering CD94/NKG2 receptors: preferential response to an HLA-G-derived nonamer. Eur J Immunol. 1998 Sep;28(9):2854-63. [Content Brief]
[13]. Hilary L Hoare, et al. Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-E by the CD94-NKG2 natural killer cell receptors. J Mol Biol. 2008 Apr 11;377(5):1297-303. [Content Brief]